Who invested in Bioventus

2 rounds we have observed, with the 2 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Healthcare

Funding summaryUpdated 26 Oct 2026

$412Mraised across 2 rounds since 2014, from 2 sources

$12MDebt$400MDebt

Latest round: Debt, $400MJul 2025
Step-upi: 33.3×
Investors: 2

See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

20162018202020222024

$12MDebt$400MDebt

First round: Debt, $12M
Biggest round: $400M
Between rounds: 10.7 years

The rounds

Jul 2025
Debt$400M1 new
- Wells Fargo
Source recorded
Oct 2014
Debt$12M1 new
- Alcentra Group
From a historical funding record

Founders and team

From Bioventus's own website: 9 on the team.

Mark SingletonSenior Vice President and Chief Financial Officer
Robert ClaypooleChief Executive Officer
Anthony D’AdamioSenior Vice President and General Counsel
Jane FitzpatrickVice President of Medical Affairs
Jeff CiardiVice President of Strategic Accounts and Market Access
Kellie StefaniakVice President of Global Regulatory and Quality
Mike CroweSenior Vice President, Operations
Sharath BhatVice President/General Manager, EMEA APAC
Katrina ChurchChief Compliance Officer

Who was in which round

The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.

Debt2014Debt2025

Wells Fargo

Alcentra Group

Everyone who backed them

Wells FargoCorporate VC1round

Alcentra GroupAngel1round

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

This firm lists Bioventus as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above.